Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 5
1985 2
1987 1
1989 1
1991 1
1992 4
1993 6
1994 3
1995 3
1996 4
1997 1
1998 1
1999 1
2000 4
2001 2
2002 2
2004 2
2005 4
2006 2
2007 4
2008 5
2009 5
2010 8
2011 8
2012 10
2013 3
2015 2
2016 1
2017 3
2018 2
2019 1
2020 1
2021 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial.
von Herrath M, Bain SC, Bode B, Clausen JO, Coppieters K, Gaysina L, Gumprecht J, Hansen TK, Mathieu C, Morales C, Mosenzon O, Segel S, Tsoukas G, Pieber TR; Anti-IL-21–liraglutide Study Group investigators and contributors. von Herrath M, et al. Lancet Diabetes Endocrinol. 2021 Apr;9(4):212-224. doi: 10.1016/S2213-8587(21)00019-X. Epub 2021 Mar 1. Lancet Diabetes Endocrinol. 2021. PMID: 33662334 Clinical Trial.
Hypoglycemia and insulin treatment.
Febo F, Molinari C, Piatti PM. Febo F, et al. Among authors: piatti pm. J Endocrinol Invest. 2011 Oct;34(9):698-701. doi: 10.1007/BF03345405. J Endocrinol Invest. 2011. PMID: 22156904 No abstract available.
Basal insulin and cardiovascular and other outcomes in dysglycemia.
ORIGIN Trial Investigators; Gerstein HC, Bosch J, Dagenais GR, Díaz R, Jung H, Maggioni AP, Pogue J, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S. ORIGIN Trial Investigators, et al. N Engl J Med. 2012 Jul 26;367(4):319-28. doi: 10.1056/NEJMoa1203858. Epub 2012 Jun 11. N Engl J Med. 2012. PMID: 22686416 Free article. Clinical Trial.
A novel surrogate index for hepatic insulin resistance.
Vangipurapu J, Stančáková A, Kuulasmaa T, Paananen J, Kuusisto J; EGIR-RISC Study Group; Ferrannini E, Laakso M. Vangipurapu J, et al. Diabetologia. 2011 Mar;54(3):540-3. doi: 10.1007/s00125-010-1966-7. Epub 2010 Nov 25. Diabetologia. 2011. PMID: 21107521
Influence of endogenous NEFA on beta cell function in humans.
Rebelos E, Seghieri M, Natali A, Balkau B, Golay A, Piatti PM, Lalic NM, Laakso M, Mari A, Ferrannini E. Rebelos E, et al. Among authors: piatti pm. Diabetologia. 2015 Oct;58(10):2344-51. doi: 10.1007/s00125-015-3685-6. Epub 2015 Jul 10. Diabetologia. 2015. PMID: 26160433
93 results